isomethyleugenol has been researched along with Paraganglioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankfalvi, A; Griewank, K; Hadaschik, E; Horn, S; Jansen, P; Kretz, J; Kutzner, H; Livingstone, E; Lutsik, P; Mayakonda, A; Möller, I; Müller, H; Murali, R; Paschen, A; Philip, M; Plass, C; Riedel, A; Rose, C; Schadendorf, D; Schaller, J; Stadtler, N; Sucker, A; Zaremba, A; Zimmer, L | 1 |
| Shine, B | 1 |
2 other study(ies) available for isomethyleugenol and Paraganglioma
| Article | Year |
|---|---|
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
Topics: Diagnosis, Differential; DNA Copy Number Variations; Humans; Melanoma; Methylation; Nevus, Epithelioid and Spindle Cell; Paraganglioma; Skin Neoplasms; Syndrome | 2022 |
Gene targeting through o-methylated catecholamine metabolite patterns.
Topics: Adrenal Gland Neoplasms; Biomarkers; Catecholamines; Gene Targeting; Humans; Methylation; Mutation; Paraganglioma; Pheochromocytoma | 2011 |